SCRIB and neoplasm: However, the fact that blocking aPKC signalling in scrib- + NACT tumours retards tumour overgrowth suggests that loss of Scrib can also contribute an aPKC-dependent increase in either cell proliferation or cell survival that can profoundly influence the rate of tumour overgrowth.